US and UK ‘lead push against global patent pool for Covid-19 drugs’
Countries with major pharmaceutical companies argue they need patents to guarantee sufficiently high prices in wealthy nations to recoup their research and development costs.
US and UK ‘lead push against global patent pool for Covid-19 drugs’
Countries with major pharmaceutical companies argue they need patents to guarantee sufficiently high prices in wealthy nations to recoup their research and development costs.
Donald Trump willing to work with China on coronavirus vaccine for US
“We’re willing to work with anybody that is going to get us a good result,” Trump said
Don’t know if I can believe this!
US bets on untested company to deliver COVID-19 vaccine
ApiJect’s devices are self-contained, with soft plastic blisters that are squeezed, like a nose spray or eye drop, to push the vaccine through an attached needle and into the patient.
The device includes a little computer chip — like the ones in credit cards — that can transmit information about the drug, dose, location and time of administration. The chip is not injected into patients.
…
When AP reached out directly to Trump’s vaccine czar, Moncef Slaoui, to discuss the new technology, a spokesperson said the query was inappropriate.

Beijing approves experimental Covid-19 vaccine for use in Chinese military
The vaccine, known as Ad5-nCoV, was jointly-developed by the Beijing Institute of Biotechnology — part of the Chinese government’s Academy of Military Medical Sciences — and vaccine company CanSino Biologics.
The NIH claims joint ownership of Moderna’s coronavirus vaccine
Why it matters: Because the federal government has an actual stake in this vaccine, it could try to make the vaccine a free or low-cost public good with wide distribution, if the product turns out to be safe and effective.
Wisconsin expert predicts there will be a shortage of eventual COVID-19 vaccine
Even when the vaccine becomes available, it might not be safe for everyone to get vaccinated
You must be logged in to post a comment.